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Abstract
System A, the Naþ-dependent amino acid transport activity, is encoded by the ATA2 gene and up-regulated following partial
hepatectomy (PH), and its competitive inhibition interferes with liver regeneration. Rabbit polyclonal antibody was raised against a
portion of the ATA2 gene product followed by immunodetection of ATA2 in isolated liver plasma membrane and lysate. The level
of ATA2 increased in the plasma membrane following PH, while the relatively high quantity of ATA2 found in liver lysate remained
constant. We also have shown that Northern analysis of steady-state ATA2 mRNA revealed no significant change following PH.
These data show that ATA2-mediated transport is not regulated by the steady-state level of ATA2 mRNA but is regulated by the
amount of ATA2 and redistribution to the plasma membrane. We hypothesize that ATA2 activity is regulated by recruitment of
ATA2 protein from an intracellular compartment. In addition, the pattern of expression of System A activity in oocytes, transport
kinetics, and sensitivity to chemical modification indicate the presence of a second System A isoform in liver that differs substantially
from ATA2.  2002 Elsevier Science (USA). All rights reserved.
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Unlike any other organ, the liver can regenerate fol-
lowing damage or surgical resection. Following 70%
resection of rat liver, this regenerative process is re-
markable with the liver regaining its original mass
within 7 to 10 days [23]. The early regenerative response
is complex and characterized by changes in the ion flux
at the hepatocyte membrane [25], changes in signal
transduction and immediate early gene expression
[10,41], expression of oncofetal proteins [11], increased
amino acid uptake [12,26,29], and induction of DNA
synthesis [18]. Optimal regeneration has been shown to
depend on an adequate supply of nutrients, several
hormones, growth factors, and cytokines.
Adequate nutrients [5], most notably amino acids
[24,31,36], have been demonstrated as essential for
normal liver regeneration, but the role of specific plasma
membrane amino acid transporters during liver regen-
eration has remained elusive. ‘‘System A,’’ the Naþ-de-
pendent transporter of small, neutral amino acids, has
received much attention in studies correlating its activity
to liver regeneration [12,14,26], gluconeogenesis [19,30],
cell volume control [22], and entry into the cell cycle
[2,9,34,35]. N-(Methylamino)isobutyric acid (MeAIB),1
the prototypical System A substrate and a competitive
inhibitor of transport [8], has been demonstrated to in-
hibit the robust proliferation of hepatocytes following
PH [14]. Despite intense study for the past two decades,
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the cloning of cDNAs encoding gene products display-
ing transport activities partially or completely consistent
with System A has only recently been reported. GlnT
[42] and SAT2 [43] both transport MeAIB in a Naþ-
dependent manner, the property synonymous with Sys-
tem A activity, but neither GlnT or SAT2 is expressed in
liver, implying little or no role for these genes in hepatic
regeneration. Fortunately, ATA2 [38] (as well as the
identical SA1 [33]) displays transport characteristics
consistent with System A, is widely expressed in many
tissues, and exhibits particularly strong expression in
liver.
Our laboratory has previously demonstrated that the
steady-state ATA2 mRNA level in regenerating liver
does not correlate with the 3- to 5-fold increase in
ATA2-mediated amino acid transport activity following
PH [13]. These observations indicate that ATA2-medi-
ated transport is regulated beyond the level of tran-
scription, perhaps at the level of translation or
posttranslation. Unfortunately, the study of posttran-
scriptional events requires a probe specific for the ATA2
gene product such as an antibody to the ATA2 protein.
To meet this need, our laboratory produced affinity-
purified polyclonal rabbit antibody specific for a region
of the ATA2 gene product which was utilized in the
measuring of ATA2 protein levels in liver tissue and
hepatic plasma membrane vesicles (HPMV) following
PH.
We utilized regenerating liver as a well-described
model for monitoring the regulation of ATA2-mediated
transport activity at the mRNA and protein levels. We
describe the regulation of ATA2-mediated transport
activity by an apparent redistribution of gene product to
the plasma membrane. This was found to correlate well
with the steady-state mRNA level of ATA2, the ex-
pression of System A transport activity from regener-
ating liver mRNA in oocytes, and System A transport
kinetics in HPMVs. Our results also indicate that two
System A-like transport activities are induced following
PH which differ substantially in kinetic properties and in
the mechanisms of regulation.
Materials and methods
Partial hepatectomy. Adult male Sprague-Dawley
rats, 200–250 g, were obtained from Harlan-Sprague-
Dawley, Indianapolis, Indiana. All experiments were
approved by the Omaha Veterans Administration
Medical Center Institutional Animal Care and Use
Committee and comply with the guidelines set by the
National Institutes of Health. Rats were maintained
under a controlled temperature with a 12 h light-dark
cycle for at least 5 days before use in experiments.
Standard rodent chow and water were provided ad lib-
itum. Between 8 and 10 Am, animals were anesthetized
with ketamine (75–100 mg/kg) and acepromazine (2.5
mg/kg) followed by 70% PH as described by Higgins and
Anderson [23]. Before closing of the abdominal wall, the
peritoneum was filled with normal saline (0.5% of body
weight). Animals were placed on a 25–30 C pad until
alert, and then they were transferred to a cage contain-
ing food and water. Animals were reanesthetized before
collection of liver at the times described in the individual
experiments.
Preparation of hepatic plasma membrane vesicles.
Plasma membrane-enriched vesicles were prepared from
regenerating rat liver by a modification of a Percoll
gradient technique [32] as previously described [12].
Plasma membrane vesicles were resuspended in SEB
(250 mM sucrose, 1 mM magnesium chloride, and 10
mM Hepes; pH 7.5), aliquoted, and stored at )70 C.
Each aliquot was thawed on ice and used only once.
Protein content was determined by a modification of the
Lowry method.
Vesicle amino acid transport assay. Naþ-dependent
and Naþ-independent uptake of amino acid was deter-
mined as previously described [12]. Briefly, after prew-
arming to 37 C for 1 min, 20 ll of an uptake solution
(0.005 to 5 mM labeled MeAIB, 20 mM Hepes, 2 mM
magnesium chloride, 100 mM sodium, or potassium
thiocyanate, pH 7.5) was added to a 20-ll aliquot of
plasma membrane vesicle solution. After 10 s, uptake
was terminated by the addition of 1 ml of ice-cold PBS
(150 mM sodium chloride and 10 mM sodium phos-
phate, pH 7.5) followed by immediate filtration through
a 0.45-lm nitrocellulose filter under vacuum. The filter
was washed twice with 4 ml of ice-cold PBS. Uptake of
labeled compound trapped in the vesicles was measured
by scintillation spectrophotometry. Sodium-dependent
uptake is expressed as picomoles of substrate per milli-
gram of protein per 10 s after subtracting the uptake
velocity in the absence of sodium from the uptake ve-
locity in the presence of sodium. A Naþ-dependent
overshoot was observed for the concentration range of
MeAIB used (data not shown). In experiments utilizing
chemical modification of System A activity with N-
ethylmaleimide (NEM), vesicles were incubated in 1
mM NEM for 20 min at 37 C, and pairwise controls
were incubated in an equal volume of vehicle (water)
and then placed on ice. System A activity was then de-
termined at 25 C by the rapid filtration method de-
scribed above.
Expression and purification of ATA2 fusion protein.
The 50 (TATGAAACAGAATTTCATCCA-OH) and 30
(CAACTCATATTTCACTATGAA-OH) oligonucleo-
tide primers were designed for use in RT-PCR to gen-
erate a 336-bp fragment of ATA2 from rat liver mRNA.
Total RNA was isolated from rat liver using a QIAgen
(Santa Clara, CA) total RNA kit, followed by RT-PCR
using the QIAgen One-Step kit, 1 lg rat RNA, and 0.4
lM of each primer. Reverse transcriptase reactions were
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exactly as described by the manufacturer, and the PCR
was conducted for 30 cycles of 94, 52, and 72 C for 1
min each. RT-PCR of ATA2 was highly specific pro-
ducing only a single 336-bp product which was cloned
into the pBAD-TOPO (Invitrogen, Carlsbad, CA) vec-
tor and transformed into Escherichia coli Top 10. Pu-
tative clones were screened for direction by nucleotide
sequencing and evaluated for L-arabinose-inducible
production of a 6His fusion peptide. The clone which
demonstrated the best production of fusion peptide was
designated pBAD:ATA2(0! 1) and retained for use in
all subsequent experiments.
ATA2 fusion peptide was purified utilizing nickel-
nitrilotriacetic acid (Ni-NTA) metal-affinity chromato-
graphy. E. coli Top10::pBAD:ATA2(0! 1) cells were
grown in 4 L of standard M9 media containing 0.5%
glycerol, 0.005% glucose, 0.1% casamino acids, and 100
mg/L ampicillin to an OD600 of 0.6 before a 4-h induc-
tion of fusion peptide expression with 0.04% L-arabi-
nose. Fusion peptide was then purified using the batch
purification under denaturing conditions as described by
the manufacturer of the Ni-NTA resin (The QIAex-
pressionist Handbook, QIAgen). Peptide purity was
>99% as assessed by Coomassie stain of proteins fol-
lowing SDS–PAGE.
Production of polyclonal ATA2 antibody. Polyclonal
antibody was prepared by injecting a portion of the
ATA2 gene product, as an antigen, into New Zealand
White rabbits utilizing standard protocols. The antigen
was expressed in E. coli as described above and corre-
sponds to amino acid residues 62 to 173 of the rat ATA2
gene product [38]. Adult male rabbits were obtained
from Harlan-Sprague-Dawley, Indianapolis, Indiana.
All experiments were approved by the Omaha Veterans
Administration Medical Center Institutional Animal
Care and Use Committee and comply with the guide-
lines set by the National Institutes of Health. ATA2
fusion peptide (250 lg) emulsified in Freund’s complete
adjuvant was injected subcutaneously. An additional
immunization was administered after 14 days using
Freund’s incomplete adjuvant. The animals were bled 2
weeks later, and the antibody titer specific for the orig-
inal antigen was measured by ELISA. The antisera were
then affinity-purified to the original antigen conjugated
to nitrocellulose [20]. Specificity for native ATA2 pro-
tein was established by comparison of the affinity-puri-
fied antisera to preabsorbed antisera in Western blots of
HPMV proteins.
Western blotting. The amount of ATA2 protein pre-
sent in liver tissue and HPMVs was determined by
Western blot [1]. Proteins, 100 lg, were separated
through a 10% SDS–PAGE and blotted to nitrocellu-
lose. After blocking with 3% BSA in TBST for 2 h, the
blot was incubated with a 1:100 dilution of affinity-pu-
rified anti-ATA2 overnight at 4 C. Binding of anti-
ATA2 was detected by incubation with secondary al-
kaline-phosphatase conjugated anti-rabbit IgG followed
by visualization with BCIP/NBT.
Northern blotting. Partial hepatectomies were per-
formed on rats as described above, and total RNA was
isolated from flash frozen liver harvested 0, 3, 6, and 12
h following surgery using a modification of the acid
phenol extraction method (Trizol, Gibco BRL, Grand
Island, NY). Northern blotting was by standard meth-
odology [1]. Denaturing formaldehyde gels were run
using 15 lg of RNA per lane followed by blotting to
nitrocellulose membranes. High specific activity single-
stranded riboprobe was generated using ½32PATP, T4
RNA polymerase (Ambion, Austin, TX), and HindIII-
digested pCRII:ATA2(0-l) as a template. Labeled probe
was separated from unincorporated ½32PATP by gel
filtration. Hybridization was performed at 42 C in 50%
foramide, 5 SSC, 0.1% SDS containing 10 lg/ml
sheared herring testis DNA for 16–24 h. Blots were
washed twice in 1 SSC for 10 min at room temperature
followed by 3 washes for 10 min at 42 C in 0.1 SSC.
Washing was completed with 3 high-stringency washes
in 0.01% SSC at 42 C for 10 min each. Hybridized
ATA2 probe was then visualized using a Molecular
Dynamics SF phosphorimager.
Expression of System A activity from regenerating li-
ver mRNA in oocytes. Liver tissue samples were collected
at 6 and 12 h following PH and frozen in liquid nitrogen.
Control tissue was collected from resected liver at the
time of surgery. mRNA was isolated from liver tissue
using a direct mRNA isolation kit (Oligotex, QIAgen,
Inc.). RNA quantity and quality were determined by
ultraviolet spectroscopy and denaturing agarose elec-
trophoresis, respectively, before injection of oocytes.
Frogs, Xenopus laevis, were kept in tanks of dechlo-
rinated tap water on a 12-h light/dark cycle at 19 C and
fed a diet of dehydrated liver in Xenopus 1 chow three
times per week. Frogs were anesthetized by immersion
in cold 0.12% 3-aminobenzoic acid ethyl ester for 20
min. Ovarian lobes were removed through a small in-
cision in the frog’s abdomen and placed in a modifica-
tion of Barth’s solution (88 mM NaCl, 1 mM KCl, 2.4
mM NaHCO3, 10 mM Hepes, 0.82 mM MgSO4, 0.33
mM CaðNO3Þ2, 0.91 mM CaCl2, pH 7.5). Oocytes were
further treated as described below before injection of
mRNA.
Before microinjection of mRNA into oocytes, the
oocytes were incubated in a collagenase solution to re-
move the follicular cell layer using standard protocols.
An aliquot of mRNA (1 mg/ml) was drawn into a glass
micropipette (10–20 lm tip size) and 50 nl injected into
the animal/vegetal pole equator for cytoplasmic deliv-
ery. After injection, the oocytes were placed into incu-
bation media (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, 5 mM Hepes (pH 7.5), 10,000 U/L pen-
icillin, 10 mg/ml streptomycin, 0.5 mM theophylline,
and 2 mM pyruvate) and left at 1822 C for 3 days to
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provide sufficient time for development of transporter
activity from the injected mRNA. Incubation media
were changed daily [17].
Oocyte amino acid transport assay. System A transport
activity was determined as previously described [27,40].
Briefly, oocytes were incubated in a sodium-free modi-
fication of incubation media to partially deplete intra-
cellular sodium pools. Some oocytes were placed into a
sodium-containing buffer with 100 lM ½14CMeAIB,
while other oocytes were placed into sodium-free buffer
containing 100 lM ½14CMeAIB. The oocytes were ex-
posed to the MeAIB for 60 min before rapid washing 3
times in ice-cold buffer lacking MeAIB. Oocytes were
transferred to individual scintillation vials and solubi-
lized in 1% SDS. Scintillation fluid was added, and the
amount of MeAIB taken up by the oocytes quantified.
Water-injected oocytes were included as controls.
Statistical analysis. All data are representative of at
least 3 independent experiments. Multiple linear re-
gression was used to analyze the kinetic data and R2
values less than 0.90 were rejected. Kinetic data dis-
playing a curvilinear Eadie–Hofstee plot were analyzed
by computer modeling (SigmaPlot 4.01, SSPE, Inc.,
Chicago, IL). Curvilinear kinetic plots were mathemat-
ically modeled to fit only two independent Michaelis–
Menton components. Least-squares approximation of
the equation of the hyperbola describing the putative
two independent transport components was fitted to two
theoretical linear components and tested for correlation.
Correlation coefficients between the experimental data
and the theoretical curves less than 0.95 were rejected.
Results
Localization of the ATA2 gene product following partial
hepatectomy
Because the highly-regulated System A amino acid
transport activity and ATA2 are synonymous [38],
Western blotting of rat HPMV proteins retaining the
severalfold induction in System A uptake activity ob-
served following PH [12] was done to check for corre-
lation between ATA2 protein levels and transporter
activity. As seen in Fig. 1, affinity-purified anti-ATA2
specifically recognized a 42- to 43-kDa protein in
HPMVs that displayed increasing intensity in HPMVs
at 6 and 12 h following PH. The appearance of increased
ATA2 in HPMVs correlates well with the System A
uptake activity measured in HPMVs following PH. We
have previously shown that basal System A transport
activity as assayed by Naþ-dependent MeAIB uptake by
HPMVs is barely discernable but rises approximately 3-
fold by 8 h after PH [12]. A surprising result was the
high level of ATA2 protein in whole liver which did not
increase following PH. The intensity of ATA2 content in
HPMV identified by immunoblotting increased by
122	 40% between 6 and 12 h (P < 0:05). The content
of ATA2 in immunoblots of total liver homogenate was
not different over the time course of liver regeneration
with the intensity 6 h equaling 88	 15% of that at 12 h
(no significant difference). This distribution of ATA2
protein suggests that a putative regulatory mechanism
for ATA2-mediated transport activity is the recruitment
of a large intracellular pool of ATA2 protein from an
intracellular compartment to the plasma membrane.
Steady-state mRNA level of ATA2
Northern hybridization of an ATA2 probe to liver
RNA resulted in the identification of homologous
mRNAs of approximately 4.5 kb exactly as previously
reported by Sugawara et al. [38]. As seen in Fig. 2, the
ATA2 steady-state mRNA levels were remarkably sim-
ilar at 3, 6, and 12 h following PH. We have previously
shown that these mRNA levels are not markedly dif-
ferent from sham-operated animals [13]. The level of
ATA2 mRNA may have been increased 3 h following
PH by 26	 8%, but did not reach a level of statistical
significance (percentage of sham control). At 6 and 12 h,
ATA2 mRNA following PH was not different from
control levels (21	 14 and 11	 9%, respectively).
Fig. 1. The level of ATA2 gene product in hepatic plasma membrane vesicles and unfractioned liver protein. Shown is a representative immunoblot of
three experiments. Total liver proteins (lanes 7–9) or proteins from isolated liver plasma membranes (lanes 1–6) were separated by SDS–PAGE,
transferred to nitrocellulose, and probed with affinity-purified anti-ATA2 as described under Materials and methods. Protein samples were collected
at 0 (lanes 1, 2, and 7), 6 (lanes 3, 4, and 8), or 12 h (lanes 5, 6, and 9) following PH. The ATA2 content as the average of densitometric analyses
(percentage of time zero) is reported in the text.
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Regardless of the potential slight increase in ATA2
mRNA at 3 h, there is no change in the amount of total
ATA2 gene product in liver at 6 and 12 h. Our results
show no significant change in ATA2 mRNA following
PH and correlate well with the stable amount of ATA2
protein observed in whole liver tissue during a 12-h
period of liver regeneration.
Appearance of System A-activating mRNA following
partial hepatectomy
Previous phenomenological studies utilizing vesicles
or cells have proposed that up-regulation of System A-
mediated transport activity is dependent on the de novo
synthesis of mRNAs [19]. Because the steady-state level
of ATA2 mRNA was unchanged following PH, our data
did not correspond with these prior observations of
others. To address this lack of correlation, we measured
the System A activity expressed in oocytes from mRNA
isolated from regenerating liver. Despite the marked
increase in MeAIB uptake velocity in plasma membrane
vesicles at 6 h, there was no augmentation of basal Sys-
tem A transport activity in oocytes microinjected with
mRNA isolated from regenerating liver at 6 h (Fig. 3)
compared to presurgical values. However, increased
System A activity was observed in oocytes injected with
mRNA collected from regenerating liver 12 h after PH, a
finding inconsistent with the unchanged steady-state le-
vel of ATA2 mRNA found in regenerating liver (Fig. 2).
These data indicate a fundamental difference between the
ATA2 mRNA level measured in liver following PH and
the appearance of System A-activating mRNAs isolated
from regenerating liver at the corresponding time points.
System A activity following partial hepatectomy
Because of the discrepancy between the oocyte ex-
pression of System A activity and Northern analysis of
ATA2 steady-state mRNA levels, the Naþ-dependent
uptake of MeAIB was examined by analysis of its kinetic
properties in an attempt to resolve the conflicting find-
Fig. 2. Liver ATA2 mRNA steady-state levels following PH. RNA
isolated from liver following PH 0 (lane 1), 3 (lanes 2 and 3), 6 (lanes 4
and 5), and 12 h (lanes 6 and 7) following surgery was subjected to
Northern hybridization to a 32P-labeled ATA2 probe as described
under Materials and methods. The percentage of sham-operated con-
trol is reported in the text.
Fig. 3. Expression of regenerating rat liver mRNA in oocytes. RNA
was isolated from regenerating liver 0, 6, or 12 h following PH and
injected into oocytes to measure the appearance of System A-activat-
ing mRNAs as described under Materials and methods. Water-injected
oocytes were included as controls. Data are the means	SD of 6 oo-
cytes, injected in a paired manner, and are representative of 3 experi-
ments.
Fig. 4. Sodium-dependent uptake of MeAIB into hepatic plasma
membrane vesicles. Vesicles were prepared from regenerating liver at 0
(d), 6 (
), and 12 (.) h following PH. Transport of 0.005 to 5 mM
MeAIB was determined as described under Materials and methods
(A). Panel B summarizes the evaluation of Michaelis–Menton com-
ponents to transport in hepatic plasma membrane vesicles. A single
component to transport was identified at 0 and 6 h with a Km of
0:24	 0:06 or 0:38	 0:03 mM and a Vmax of 484	 55 or 1454	 60
pmol MeAIB/mg protein/10 s, respectively. Two components to
transport were identified at 12 h with a Km of 0:27	 0:3 or 5:62	 0:42
mM and a Vmax of 1530	 220 or 6530	 430 pmol MeAIB/mg protein/
10 s for the high- and low-affinity components, respectively. Data are
representative of three vesicle preparations.
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ings. The kinetic data and their derivation are summa-
rized in Eadie–Hofstee plots shown in Fig. 4. Reflecting
the low System A activity in normal adult rat liver,
HPMVs prepared from sham animals were found to
contain a minimal level of System A transport activity.
The basal System A transport determined from vesicles
prepared from presurgery quiescent liver was character-
ized by a low level of activity with a calculated Vmax of
484	 55 pmol MeAIB mg protein1 10 s1 and Km of
0:24	 0:06 mM. Plasma membrane vesicles prepared 6 h
following PH contained a markedly elevated System A
activity. The kinetic analysis of System A amino acid
transport at 6 h following PH revealed a Vmax of
1454	 60 pmolMeAIBmg protein1 10 s1 with a Km of
0:38	 0:03 mM. Only one statistically significant com-
ponent to transport at 6 h following PH was discernable
by kinetic analysis of MeAIB uptake. The Km of System
A activity at 0 and 6 h following PH are consistent with
values reported in the literature for ATA2 [33,38], indi-
cating that the transport activity is mediated by the
ATA2 gene product. A high Km component to System A
activity appeared at 12 h following PH with a Km of
5:62	 0:42 mM and a Vmax of 6530	 430 pmol MeAIB
mg protein1 10 s1. The Vmax of the low Km System A
component at 12 h displayed an increase in Vmax at 12 h,
relative to uptake at 6 h, with almost no change in Km
Thus, the kinetic analysis of System A activity at 12 h
indicates the appearance of a high Km transport activity,
and an additional increase in Vmax for the low Km uptake
component. These data provide biochemical evidence for
the stepwise appearance of two distinct System A
transport activities following PH the low Km component
of which can be attributed to the ATA2 gene product
while the high Km component appears to result from ei-
ther another gene product or, less likely, a modification
of the ATA2 transporter.
Inactivation of MeAIB transport by NEM
Inherent differences in System A transport between
normal liver and transformed hepatic cell lines have
been previously suggested by differential responses to
sulfhydryl-specific reagents [6,7]. NEM decreased Sys-
tem A-mediated transport in normal hepatocytes, but
did not affect System A activity in hepatoma cells [6,7].
In the present study, the effect of chemical modification
by NEM on each of the two components to System A
activity after PH was tested for corroborative evidence
for the presence of distinct System A transporters. We
found that the System A transport component present in
HPMV 6 h following PH was almost completely inac-
tivated by NEM treatment, while the transport activity
in HPMV at 12 h was resistant to NEM (Fig. 5). These
findings agree with the kinetic and oocyte expression
data indicating two distinct transport activities com-
prising System A in regenerating liver following PH.
Discussion
The production of an anti-ATA2 antibody provides a
method for the direct examination of the amount of
ATA2 gene product in subcellular fractions without the
absolute requirement for the transport protein to be in a
state suitable for the assaying of its activity. For ex-
ample, the measurement of System A in Golgi [4] would
not have been possible if the transporter was not active
in vesicular preparation of subcellular fractions (a for-
tuitous situation), and the direct measurement of rela-
tive transporter protein level has not been previously
possible, making characterization of the gene product
impractical. Our findings indicate that the amount of
ATA2 gene product in the hepatic plasma membrane
increases while the total amount present remains con-
stant. Since the amount of ATA2 protein in the cell, on a
per milligram protein basis, is much higher than the
amount of ATA2 appearing in the hepatic membrane
following PH, we hypothesize that the mechanism of up-
regulating ATA2-mediated amino acid transport is by a
redistribution of ATA2 protein from an intracellular
compartment to the plasma membrane. The lack of an
increase in the steady-state level of ATA2 mRNA, taken
in the context of no increase in the amount of ATA2
gene product in whole cell lysate following PH, supports
the hypothesis that regulation occurs after the tran-
scription and translation of the ATA2 gene.
Recently, others have reported a correlation between
the steady-state ATA2 mRNA level and ATA2-medi-
ated amino acid uptake [16], as well as a change in the
subcellular location and amount of the ATA2 gene
product [28], in an in vitro model of System A activity
induction through the process of adaptive regulation.
Adaptive regulation is the up-regulation of System A
activity by cells incubated in media devoid of amino
acids and the subsequent decay of transport upon the
addition of a single System A amino acid substrate.
While the study of adaptive regulation of ATA2 will no
Fig. 5. Inhibition of transport by NEM. HPMVs were isolated from
regenerating liver 0, 6, or 12 h following PH and the inhibition of 50
lMMeAIB uptake by 1 mMNEM was determined as described under
Materials and methods. Data are the means	SD of 3 determinations.
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doubt reveal unique insight to the regulation of ATA2-
mediated transport, these observations are not likely to
directly apply to the PH model because amino acids are
readily available in vivo and the concentrations of Sys-
tem A substrate amino acids in peripheral blood actually
increase following PH [14].
The hypothesis that System A activity can be in-
creased in the absence of de novo mRNA and protein
synthesis has been previously postulated [15,27]. Gazzola
et al. [15] describe a starvation-enhanced increase in
L-proline transport (attributed to System A) by fibro-
blasts in a cycloheximide-insensitive process. In addition,
the division of System A activity into mRNA-dependent
and mRNA-independent components has been
described by Lin et al. [27]. In their investigations, insulin
treatment of GF-14 lymphocytes resulted in increased
System A uptake activity and increased expression of
System A-like transport activity in oocytes injected with
fractionated mRNA. These data suggest that System A
activity is regulated by the transcription of System
A-activating mRNAs, presumably those of the trans-
porter itself. However, in the same study, insulin treat-
ment of Ehrlich cells resulted in increased System A
transport activity with no significant change in the
expression of System A activity in oocytes. Together,
these observations indicated the existence of at least two
isoforms of System A amino acid transporter which
differ substantially in kinetic properties and mechanism
of regulation.
Our observations indicate that both isoforms of
System A transport activities are increased in liver fol-
lowing PH, and that the mRNA-independent activity
appears in HPMV before any System A-activating
mRNAs are detected in oocytes. Because the System A
activity present in liver at 6 h following PH does not
correlate with the appearance of System A-activating
mRNAs expressed in oocytes, this activity resembles the
activity described in Ehrlich cells, while the System A
activity in liver at 12 h mirrors the appearance of System
A-activating mRNAs expressed in oocytes, suggesting a
System A activity consistent with that found in GF-14
lymphocytes. The differential sensitivity to NEM of
System A activity found in HPMV following PH pro-
vides additional evidence for the presence of two distinct
activities in liver.
Indeed the recent cloning of ATA3 cDNA [39], which
codes for a System A-like transport activity, correlates
well with these findings. ATA3 is expressed almost ex-
clusively in liver and skeletal muscle [21,39] bringing the
number of known System A-like transporters expressed
in liver to 2 (ATA2 and ATA3). In addition, the re-
ported Km of ATA3 for MeAIB is in the 4–6 mM range
which is consistent with the high Km component to
transport reported in this study. Finally, the presence of
cysteine residues in ATA3 at amino acid positions 18
and 26, not found in ATA2, potentially confers, the
sensitivity of the high Km component of transport to
NEM. If ATA3 is indeed responsible for the high Km
component to transport, our findings indicate that its
activity is regulated by the steady-state level of activat-
ing mRNAs. However, assignment of ATA3 as the high
Km transport activity up-regulated in liver following PH
has yet to be directly demonstrated, and evaluation of
ATA3 following PH was beyond the scope of this in-
vestigation. However, we are in the process of devel-
oping the antibodies and nucleic acid probes to critically
evaluate ATA3 in this model.
The up-regulation of System A-mediated amino acid
transport following PH [12,26,29] is integral to optimal
liver regeneration [14]; however, the role of increased
amino acid uptake following PH and liver regeneration
has remained elusive. The appearance of two System A-
like transport activities early in the liver regeneration
process may help explain the difficulty in identifying a
specific role for increased amino acid uptake in this
model of cell proliferation and growth. There is a
distinct possibility that each System A component
performs a different physiological function during re-
generation and that the mechanisms of induction and
mode of action for each differ significantly. The findings
presented in this study indicate that ATA2 is regulated
by the redistribution of the ATA2 gene product to the
plasma membrane following PH and suggest that the
high Km component to System A transport is regulated
at the level of mRNA. Since the rate constants for each
System A component differ by approximately one order
of magnitude, the differential appearance of each system
would potentially impact the rate at which substrate
amino acids are available for intracellular processes. The
well-documented induction of System A amino acid
transport following PH [12,26] and exposure to gluca-
gon [4,19] and during movement into the cell cycle [3,9]
are examples of up-regulated amino acid transport
presumably providing increased nutrition for regenera-
tion, substrate for gluconeogenesis, and macromolecule
precursors for cell proliferation, respectively. The dif-
ference in transport rate, and the resulting cytoplasmic
availability of substrate [37], could regulate some of the
processes fueled by System A transport activity. How-
ever, characterization of these amino acid transport
systems at the molecular level is in its infancy, and the
future unraveling of the role that each System A com-
ponent plays in liver regeneration will enhance the un-
derstanding of this unique phenomenon.
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